Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,441 | 47,324 | 84,265 | 56,445 | 27,211 |
| Marketable Securities | 130,851 | 125,414 | 231,233 | 166,434 | 48,542 |
| Other current assets | 0 | 0 | 220 | 502 | 783 |
| TOTAL | $194,051 | $176,994 | $319,721 | $228,154 | $78,797 |
| Non-Current Assets | |||||
| PPE Net | 62,141 | 71,705 | 82,785 | 57,967 | 15,385 |
| Investments And Advances | 31,346 | 89,637 | 53,114 | 137,463 | 1,962 |
| Intangibles | 34,200 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 31,478 | 22,355 | 30,924 | 13,791 | 10,632 |
| TOTAL | $159,165 | $183,697 | $166,823 | $209,221 | $27,979 |
| Total Assets | $353,216 | $360,691 | $486,544 | $437,375 | $106,776 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 82 | 584 | 7,368 | 2,019 | 0 |
| Accounts payable and accrued liabilities | 3,075 | 2,741 | 5,454 | 7,596 | 8,082 |
| Accrued Expenses | 17,461 | 10,149 | 9,841 | 6,040 | 4,030 |
| TOTAL | $129,782 | $17,846 | $29,817 | $15,655 | $12,112 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 56 | 4,457 | 10,923 | 9,636 |
| Deferred Revenues | 109,164 | 4,372 | 7,154 | 0 | N/A |
| Other Non-Current Liabilities | 57,698 | 46,658 | 38,698 | 14,559 | 11,679 |
| TOTAL | $62,072 | $158,095 | $153,989 | $25,482 | $21,315 |
| Total Liabilities | $191,854 | $175,941 | $183,806 | $41,137 | $33,427 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,045 | 64,818 | 59,171 | 58,819 | N/A |
| Common Shares | 9 | 6 | 6 | 5 | 1 |
| Retained earnings | -782,337 | -655,771 | -519,098 | -388,166 | -292,342 |
| Other shareholders' equity | 324 | 108 | -2,462 | -650 | 147,858 |
| TOTAL | $161,362 | $184,750 | $302,738 | $396,238 | $73,349 |
| Total Liabilities And Equity | $353,216 | $360,691 | $486,544 | $437,375 | $106,776 |